Congress Combatting PBMs Perverse Incentives to Keep Costs High – DC Journal – InsideSources
A review of prescription drug formularies last year revealed that a $10,000 brand drug for prostate cancer was preferred on a formulary, while its $450
A review of prescription drug formularies last year revealed that a $10,000 brand drug for prostate cancer was preferred on a formulary, while its $450
President Biden recently held an event to celebrate that three major drugmakers announced they are putting a $35 monthly out-of-pocket price cap on asthma
In his State of the Union address, President Biden doubled down on his commitment to decreasing drug prices by expanding the number of drugs subject…
Find out about events that bring together rheumatology clinicians and professionals and their patients to directly discuss issues with stakeholders is an integral part of…
From the first moments after birth, we pay close attention to babies’ development. Right away, we’re told their length and weight. We fuss about how…
Deborah Dyett Desir, MD is the 87th ACR president and the first Black person elected to the position. In conversation with The Rheumatologist, this profile…
Weight-loss medications like semaglutide save on costs down the road. But is it enough?
Join the Biologics Prescribers Collaborative for the annual National Policy & Advocacy Summit on Biologics.
What concept represents the most important and transformational article ever written in all of rheumatology?As it turns out, coming to a consensus on the answer…
DC Legislation Information Management System
The mifepristone ruling may lead to all sorts of drugs and treatments disappearing.